Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer

HIGHLIGHTS

• who: Canxuan Li from the Department of Urology, People`s Republic of China have published the research: Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer, in the Journal: (JOURNAL)
• what: Combining the analysis, the authors developed a prognostic risk score formula, which was determined as follows: Risk score=(gene 1 expression * correspondence coefficient) + u2026 + (gene n expression * correspondence coefficient). The authors evaluated the IC50 values of several chemotherapeutic medicines concerning the various risk groups. The authors aim to assess whether the hub TILRGs identified . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.